Manufacturing and Production

Showing 15 posts of 5863 posts found.

sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
gwpharma

Cannabis-based treatment scores Phase 3 successes for GW Pharma

December 6, 2016 Manufacturing and Production, Research and Development GW Pharma, cannabidiol

UK-based GW Pharmaceuticals, a biopharmaceutical firm focused on the development of novel cannabinoid therapies, has unveiled new efficacy data for …
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016 Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …
jeffrey_eisenberg

Xenetic Biosciences promote Jeffrey Eisenberg from board member to COO

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xenetic

Xenetic Biosciences, a clinical-stage biopharmaceutical company, has announced the appointment of Jeffrey Eisenberg as chief operating officer. Mr. Eisenberg has …
merck_kapa_biosystems

Merck and Roche extend distribution ties

December 5, 2016 Manufacturing and Production Merck, Roche, distribution

Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …
entrance_takeda_i020_v1

Takeda to invest €40m in Dublin operations expansion

December 5, 2016 Manufacturing and Production Dublin, Ireland, Nanlarotm, Takeda

Takeda has announced it is to invest $40 million in a new facility in Dublin, adding a new facility and …

Mission Therapeutics announces new non-executive chairman

December 5, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mission Therapeutics, appointment

Drug discovery and development firm Mission Therapeutics has announced that it has appointed Dr Colin Goddard (pictured) as non-executive chairman …
interactions-carousel

Scientists create ‘map of drugs’ to aid further development

December 5, 2016 Manufacturing and Production, Medical Communications

Researchers at The Institute of Cancer Research have used drugs licensed through the FDA to create a map of all …
kitepharma_fullcolor_rgb

Kite Pharma names new senior VP of Supply Chain

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, kite pharma

Santa-Monica-based clinical-stage biopharmaceutical firm Kite Pharma has appointed Dr Jian Irish as senior vice president of Supply Chain, who will …
takeda_tokyo_hq

Takeda to build €100 million dengue vaccine manufacturing plant

December 1, 2016 Manufacturing and Production, Medical Communications Takeda, dengue, phase 3

Takeda have announced plans to spend more than €100 million in the construction of a new manufacturing plant in Singen, …
eisai_halaven_eribulin_web

Eisai & Clinigen to bring breast cancer drug to South Africa

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clinigen, Eisai, South Africa, breast cancer

Eisai and Clinigen have formed a collaboration to deliver the former’s cancer treatment Halaven (eribulin) to women in South Africa …
ncri-harpal-hero

Cancer Research UK announces “largest ever” development investment

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer Research UK

Cancer Research UK (CRUK) is set to inject a total of £226 million into centres across the UK over the …
happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016 Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …
The Gateway to Local Adoption Series

Latest content